- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
February 15th, 2005
We recently profiled several nanobio companies that are developing novel and improved drug delivery technologies. On the day that profile was published, nanobio company pSivida Ltd. (Nasdaq: PSDV), working on yet another competing nano-inspired drug delivery technology, listed with the Nasdaq.
Founded in 2000, pSivida is an Australian company with global ambitions, having also listed on the Frankfurt exchange. Europe's largest research organization, QinetiQ, itself majority owned by the U.K. government, is its single largest shareholder, with 17.5% of the company.
|Related News Press|
Nanometrics to Participate in the Citi 2015 Global Technology Conference August 26th, 2015
Russia’s Nano-enabled Products Market to Witness Massive Growth February 8th, 2011
Adept Technology Announces Orders for Over $600K from Chinese Partner January 18th, 2011
Nanostart-held ItN Nanovation Receives Major Follow-on Order in Saudi Arabia November 29th, 2010
Homegrown Companies Developing Batteries for Clean Energy Storage November 2nd, 2010
Small but heading for the big time: Nanobiotix half year results for the six months ended 30 June 2015, in line with expectations: Major clinical achievements and corporate developments August 28th, 2015